Murine IL-12 is involved in Calmette-Guérin bacillus-induced sensitization and is by itself sufficient to sensitize mice to the lethal effects of human TNF

Journal of Immunology

Volumn 156, Issue 12, 1996, Pages 4686-4690

  Cauwels, Anje ^a   Fiers, Walter ^a   Brouckaert, Peter ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; INTERLEUKIN 12; TUMOR NECROSIS FACTOR;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ARTICLE; CANCER PREVENTION; CANCER RESISTANCE; ENTEROBACTER INFECTION; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFECTION PREVENTION; INFECTION RESISTANCE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM BOVIS; RECEPTORS, INTERFERON; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029885845     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Fiers, W. 1995. Biologic therapy with TNF: preclinical studies. In Biologic Therapy of Cancer, 2nd Ed. V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg, eds. J. B. Lippincott, Philadelphia, PA, p. 295.
2. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
3. Liénard, D., P. Ewalenko, J.-J. Delmotte, N. Renard, and F. Lejeune. 1992. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin. Oncol. 10:52.
4. Lewis, M., L. A. Tartaglia, A. Lee, G. L. Bennett, G. C. Rice, G. H. W. Wong, E. Y. Chen, and D. V. Goeddel. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88:2830.
5. Brouckaert, P., C. Libert, B. Everaerdt, and W. Fiers. 1992. Selective species specificity of tumor necrosis factor for toxicity in the mouse. Lymphokine Cytokine Res. 11:193.
6. Cauwels, A., P. Brouckaert, J. Grooten, S. Huang, M. Aguet, and W. Fiers. 1995. Involvement of IFN-γ in bacillus Calmette-Guérin-induced but not in tumor-induced sensitization to TNF-induced lethality. J. Immunol. 154:2753.
7. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
8. Chehimi, J., S. E. Starr, I. Frank, M. Rengaraju, S. J. Jackson, C. Llanes, M. Kobayashi, B. Perussia, D. Young, E. Nickbarg, S. F. Wolf, and G. Trinchieri. 1992. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175:789.
9. + T lymphocytes, and NK cells. J. Immunol. 149:3495.
10. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospíšil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869.
11. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
12. Scott, P., and S. H. Kaufmann. 1991. The role of T-cell subsets and cytokines in the regulation of infection. Immunol. Today 12:346.
13. Bancroft, G. J., R. D. Schreiber, and E. R. Unanue. 1991. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol. Rev. 124:5.
14. Sher, A., I. P. Oswald, S. Hieny, and R. T. Gazzinelli. 1993. Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J. Immunol. 150:3982.
15. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor a are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
16. Ozmen, L., M. Pericin, J. Hakimi, R. A. Chizzonite, M. Wysocka, G. Trinchieri, M. Gately, and G. Garotta. 1994. Interleukin 12, interferon γ, and tumor necrosis factor α are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med. 180:907.
17. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilček, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259:1742.
18. Gately, M. K., R. R. Warrier, S. Honasoge, D. M. Carvajal, D. A. Faherty, S. E. Connaughton, T. D. Anderson, U. Sarmiento, B. R. Hubbard, and M. Murphy. 1994. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int. Immunol. 6:157.
19. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C. B-17 mice: reversal by IFN-γ. J. Immunol. 152:1883.
20. Tavernier, J., L. Fransen, A. Marmenout, J. Van der Heyden, R. Müller, M. R. Ruysschaert, A. Van Vliet, R. Bauden, and W. Fiers. 1987. Isolation and expression of the genes coding for mouse and human tumor necrosis factor (TNF) and biological properties of recombinant TNF. In Lymphokines, Vol. 13. D. R. Webb and D. V. Goeddel, eds. Academic Press, Orlando, FL, p. 181.
21. Ruff, M. R., and G. E. Gifford. 1981. Tumor necrosis factor. In Lymphokines, Vol. 2. E. Pick, ed. Academic Press, New York, p. 235.
22. Van Lamsweerde, A. L., N. Henry, and G. Vaes. 1983. Metastatic heterogeneity of cells from Lewis lung carcinoma. Cancer Res. 43:5314.
23. Brunda, M. J., L. Luistro, R. R. Warrier, R. B. Wright, B. R. Hubbard, M. Murphy, S. F. Wolf, and M. K. Gately. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1223.
24. + cell numbers and clinical staging. J. Clin. Invest. 84:1892.
25. Clerici, M., D. R. Lucey, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721.
26. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induction of interferon γ-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700.
27. Stevenson, M. M., M. F. Tam, S. F. Wolf, and A. Sher. 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155: 2545.
28. Orange, J. S., T. P. Salazar-Mather, S. M. Opal, R. L. Spencer, A. H. Miller, B. S. McEwen, and C. A. Biron. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901.
29. Orange, J. S., S. F. Wolf, and C. A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1253.
30. Brouckaert, P. G. G., G. G. Leroux-Roels, Y. Guisez, J. Tavernier, and W. Fiers. 1986. In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma. Int. J. Cancer 38:763.
31. Libert, C., S. Van Bladel, P. Brouckaert, A. Shaw, and W. Fiers. 1991 Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor. J. Immunol. 146:2625.
32. Everaerdt, B., P. Brouckaert, A. Shaw, and W. Fiers. 1989. Four different interleukin-1 species sensitize to the lethal action of tumour necrosis factor. Biochem. Biophys. Res. Commun. 163:378.
33. Owen-Schaub, L. B., S. M. Santee, J. L. Winkelhake, and R. J. Zimmerman. 1994. Role of tumor necrosis factor species in the sequence-dependent effects of interleukin-2/tumor necrosis factor immunotherapy in mice: implications for preclinical cytokine testing. J. Immunother. 15:1.
34. Van Ostade, X., P. Vandenabeele, B. Everaerdt, H. Loetscher, R. Gentz, M. Brockhaus, W. Lesslauer, J. Tavernier, P. Brouckaert, and W. Fiers. 1993. Human TNF mutants with selective activity on the p55 receptor. Nature 361:266.
35. Barbara, J. A. J., W. B. Smith, J. R. Gamble, X. Van Ostade, P. Vandenabeele, J. Tavernier, W. Fiers, M. A. Vadas, and A. F. Lopez. 1994. Dissociation of TNF-α cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-α mutants. EMBO J. 13:843.